Heterodimeric proteins with fc mutations
TW202629614APending Publication Date: 2026-07-16ADAGENE AG
0 Cites 0 Cited by
Patent Information
- Application Number
- TW115107855
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2021-01-22
- Publication Date
- 2026-07-16
Abstract
The present application provides heterodimeric proteins comprising polypeptides having CH3 domains with engineered residues that form disulfide bonds and / or salt bridges. Also provided are activatable antibodies targeting CD3 and / or HER2. Compositions, methods of manufacture and methods of treatment using the heterodimeric proteins and the activatable antibodies are further provided.
Need to check novelty before this filing date? Find Prior Art